Greater Cannabis Company (GCAN) Net Cash Flow Growth (5y) (2022 - 2026)
Greater Cannabis Company (GCAN) Net Cash Flow Growth (5y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.06 Bn | 87.19 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn |
| 3 | Zoetis | 32.39 Bn | 30.45 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.59 Bn | 23.53 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.19 Bn | 21.04 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 20.53 Bn | 20.53 Bn | - |
| 7 | Viatris | 20.27 Bn | 18.46 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 18.00 Bn | 16.69 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.65 Bn | 12.22 Bn | 785.00 Mn |
| 10 | Greater Cannabis Company | 292,929.85 | 292,929.85 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -68.58% |
| Dec 31, 2025 | 18.14% |
| Sep 30, 2025 | 36.00% |
| Jun 30, 2025 | 21.83% |
| Mar 31, 2025 | -15.34% |
| Dec 31, 2024 | 25.34% |
| Sep 30, 2024 | 12.51% |
| Jun 30, 2024 | 10.19% |
| Mar 31, 2024 | -18.71% |
| Dec 31, 2023 | -3.25% |
| Sep 30, 2023 | -4.03% |
| Jun 30, 2023 | -17.66% |
| Mar 31, 2023 | -17.43% |
| Sep 30, 2022 | -147.55% |
| Mar 31, 2022 | -72.43% |